RRSP Investors: Should You Buy Nutrien Stock Now?

Nutrien stock is enjoying a great run in 2022. Are more gains on the way?

| More on:
question marks written reminders tickets

Image source: Getty Images

Nutrien (TSX:NTR)(NYSE:NTR) stock is up 45% in 2022. Investors who missed the rally are wondering if the Canadian fertilizer giant is still undervalued and deserves to be in a self-directed RRSP portfolio.

Nutrien overview

Nutrien is a relatively new name on the TSX Index, but the company has been around for a long time. Potash Corp and Agrium merged in 2018 to create Nutrien. The marriage made sense given that both companies were based in Canada and already sold their potash production on the global wholesale market together through a joint partnership business called Canpotex.

Management on both sides of the deal completed major capital projects before putting the two companies together. These initiatives have helped Nutrien in the past year by providing spare potash production capacity the company is able to bring online quickly and at low cost.

Agrium contributed a strong retail business to the deal, while Potash Corp was primarily a wholesale provider of fertilizers. Nutrien is a stronger and more balanced company from a revenue perspective than either Potash Corp or Agrium before the merger. Today, Nutrien is the planet’s largest potash producer and a leading supplier of nitrogen and phosphate. Farmers around the globe use the crop nutrients to boost yields.

The retail business continues to expand through strategic acquisitions. Nutrien has the financial firepower to do deals as the sector consolidates and the company leverages its relationships with more than 500,000 farmers who buy its seed and crop protection products. Nutrien has also invested in digital technologies and services to help its clients make their businesses more efficient.

Fertilizer prices

Potash, nitrogen, and phosphate prices go through commodity cycles. The sector was already on the upswing after a multi-year slump when the pandemic hit and drove up crop prices. The surge in margins for farmers has led to an increase in acres being planted to take advantage of strong market conditions.

At the same time, the implementation of sanctions and against Belarus and now Russia have created a drop in global potash supplies. The two countries typically account for 40% of the potash sold around the globe. According to Nutrien’s Q1 2022 report these countries saw their sales dip 20% in the first three months of 2022.

Nutrien increased its potash production by one million tonnes in the second half of 2021 to fill the gap caused by the sanctions placed on Belarus last year and intends to increase output by another one million tonnes in 2022 to meet demand.

Fertilizer prices are expected to remain at elevated levels for some time, and this could be the early innings of a protracted bull market for these commodities.

Should you buy Nutrien stock now?

Nutrien raised the low end of its full-year 2022 adjusted EBITDA guidance from $10 billion to $14.5 billion when it reported Q1 2022 earnings results. This is a material upgrade, and while the market might have had some of it already priced into the stock, the share price still might not fully reflect the revenue and free cash flow potential.

At some point down the road, crop nutrient prices will peak again and tumble before starting a new cycle. That might not happen for quite a while, and Nutrien’s share price has the potential to move significantly higher before that occurs.

The stock currently trades near $133 per share compared to the 2022 high around $148. If you have some cash to put to work in a self-directed RRSP, this stock deserves to be on your radar.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Nutrien Ltd. Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

A worker uses a double monitor computer screen in an office.
Tech Stocks

Here’s Why Constellation Software Stock Is a No-Brainer Tech Stock

CSU (TSX:CSU) stock was a no-brainer tech stock in 1995, and it still is today, with CEO Mark Leonard providing…

Read more »

stock data
Dividend Stocks

Better Dividend Stock to Buy: Fortis vs. Enbridge

Fortis and Enbridge have raised their dividends annually for decades.

Read more »

money cash dividends
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

Canadian investors can use the TFSA to create a passive-income stream by investing in GICs, dividend stocks, and ETFs.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Friday, April 26

The release of the U.S. personal consumption expenditure data could give further direction to TSX stocks today.

Read more »

Different industries to invest in
Stocks for Beginners

The Best Stocks to Invest $1,000 in Right Now

These three are the best stocks your $1,000 can buy, with all seeing huge growth in the last year, but…

Read more »

investment research
Dividend Stocks

Better RRSP Buy: BCE or Royal Bank Stock?

BCE and Royal Bank have good track records of dividend growth.

Read more »

Payday ringed on a calendar
Dividend Stocks

Want $500 in Monthly Passive Income? Buy 5,177 Shares of This TSX Stock 

Do you want to earn $500 in monthly passive income? Consider buying 5,177 shares of this stock and also get…

Read more »

Double exposure of a businessman and stairs - Business Success Concept
Tech Stocks

Why Shares of Meta Stock Are Falling This Week

Meta (NASDAQ:META) stock plunged as much as 19%, despite beating first-quarter earnings, so what gives?

Read more »